dc.contributor.author |
Ulloque-Badaracco, Juan R. |
|
dc.contributor.author |
Hernandez-Bustamante, Enrique A. |
|
dc.contributor.author |
Herrera-Añazco, Percy |
|
dc.contributor.author |
Benites-Zapata, Vicente A. |
|
dc.date.accessioned |
2022-06-25T20:36:42Z |
|
dc.date.available |
2022-06-25T20:36:42Z |
|
dc.date.issued |
2022 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/11860 |
|
dc.description.abstract |
We disagree with what the authors mentioned about interpreting the odds ratio (OR) of the ApoB/A1 ratio. In the interpretation of a measure of association estimated by meta-analysis (MA), there are two considerations: statistical significance, evaluated using p-values and confidence intervals (CI), and clinical significance, evaluated using direction and magnitude of effect (strength of association)... |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
Elsevier |
|
dc.relation.ispartofseries |
Travel Medicine and Infectious Disease |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
reply |
en_US |
dc.subject |
Conceptual interpretation |
en_US |
dc.subject |
clinical applicability |
en_US |
dc.subject |
systematic review |
en_US |
dc.subject |
Apolipoproteins |
en_US |
dc.subject |
COVID-19 patients |
en_US |
dc.title |
Reply to “Conceptual interpretation and clinical applicability of A systematic review and meta-analysis about prognostic value of Apolipoproteins in COVID-19 patients” |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1016/j.tmaid.2021.102249 |
|
dc.relation.issn |
1873-0442 |
|